Diabetech - Diabetes Tech, Research, News

Commercial airline pilot John Roth shares how his diagnosis grounded him in 2015 and forced him to step away from the cockpit. Through years of advocacy, legal challenges, and advances in diabetes technology, John helped pave the way for pilots with type 1 diabetes to regain their right to fly. The conversation explores the emotional toll of losing a passion, the role CGMs played in changing FAA policy, and the strict medical requirements pilots with diabetes must meet today.

 

Join Pilot Facebook Group

 

Learn about the Eversense 365 CGM

 

Learn about Omnipod 5 (sponsor)*

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*30-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sat down with MiniMed's CTO to explore the new app-controlled pump, the MiniMed Flex and walk through its redesigned app ecosystem. We also discussed the next-generation Vivera algorithm, designed to reduce or potentially eliminate the need for meal boluses while improving time in range for users. And in a surprise reveal, MiniMed gave us an early look at the upcoming tubeless patch pump called "MiniMed Fit", sharing details about its design, reusable components, charging system, and development timeline.

 

Learn about Omnipod 5 (sponsor)*

 

Learn about the Eversense 365 CGM

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Katie Beth Hand, patient 9 in the Eledon trial, received an islet cell transplant in January 2026. She is now living a "functionally cured" life, but every 21 days she requires a transfusion of an immunosuppressant called Tegoprubart which stops her body from attacking the newly implanted islet cells. In this conversation, we get into how the trial works, what it feels like to stop taking insulin after years of type 1 diabetes, and the complicated emotions that come with this new normal.

 

Learn about the RESET T1D study (sponsor)

 

Learn about Omnipod 5 (sponsor)*

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

Follow Katie Beth Hand: Instagram | Tik Tok  

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Dexcom has heard the community's concerns around sensor accuracy, connectivity, adhesive performance, and transparency. In this episode, I sit down with Dexcom CEO Jacob Leach and CTO Peter Simpson to discuss how the company is addressing those concerns, improving the Dexcom G7, and working to rebuild trust with users. We also get an exclusive look at the future of Dexcom, including enhanced algorithms, improved reliability, the upcoming Dexcom G8, and advancements in continuous glucose monitoring like multi-analyte sensing and potassium tracking.

 

Learn about Omnipod 5 (today's sponsor)*

 

Learn about the Eversense 365 CGM

 

T1D Exchange Registry Sign up  (US residents only)

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Sending a child to school with type 1 diabetes should be easier in 2026. In this episode I break down why it remains one of the most stressful parts of managing the disease. I sit down with Dr. Taylor Inman, a physician and parent of a child with type 1 diabetes, to unpack the major gaps in school-based diabetes care despite widespread use of CGMs and insulin pumps. We explore how outdated policies, lack of training, and limited support systems are forcing families into constant crisis mode, sometimes even pushing parents out of the workforce. We also dive into her national survey data, revealing how common these challenges are across the U.S. and what needs to change.

 

Learn about the Eversense 365 CGM

 

Learn about Omnipod 5 (today's sponsor)*

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

Join Follow T1D: Website | Instagram 

 

Dr. Taylor Inman's Survey

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.